Frederick A. Fletcher

3.6k citations

34 papers · 2.0k indexed · h-index 18

Impact in

Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Platelet Disorders and Treatments
Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 6
Immunology 10
- T-cell and B-cell Immunology 4
- Immune Cell Function and Interaction 3

Co-authors: David L. Lacey Todd Juan David J. HillYu SunDouglas E. Williams Gwyneth Van Sheila Scully Stewart D. Lyman
Journals: Blood (5 papers)The Journal of Immunology (3 papers)Genomics (3 papers)Experimental Hematology (2 papers)Journal of Clinical Oncology (2 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Frederick A. Fletcher

34 papers receiving 1.9k citations

Peers

Countries citing papers authored by Frederick A. Fletcher

Since Specialization

Citations

This map shows the geographic impact of Frederick A. Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick A. Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick A. Fletcher more than expected).

Fields of papers citing papers by Frederick A. Fletcher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick A. Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick A. Fletcher. The network helps show where Frederick A. Fletcher may publish in the future.

Co-authors

The 25 scholars most cited alongside Frederick A. Fletcher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frederick A. Fletcher Line = papers co-authored together Frederick A. Fletcher links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma Molecular Therapy ·Maurizio Ghisoli, Minal Barve, Reva Schneider, Robert Mennel, Carl Lenarsky, Gladice Wallraven, Beena O. Pappen, John LaNoue, Padmasini Kumar, Derek Nemunaitis, A Roth, James Nemunaitis, Sam H. Whiting, Neil Senzer, Frederick A. Fletcher, John Nemunaitis	2015	48
2	Mice Overexpressing Murine Oncostatin M (OSM) Exhibit Changes in Hematopoietic and Other Organs that Are Distinct from Those of Mice Overexpressing Human OSM or Bovine OSM Veterinary Pathology ·Todd Juan, Brad Bolon, Richard Lindberg, Yu Sun, Gwyneth Van, Frederick A. Fletcher	2008	13
3	Regulatory Effects of Novel Neurotrophin-1/B Cell-Stimulating Factor-3 (Cardiotrophin-Like Cytokine) on B Cell Function The Journal of Immunology ·Giorgio Senaldi, Marina Stolina, Jane Guo, Raffaella Faggioni, Susan McCabe, Stephen A. Kaufman, Gwyneth Van, Weilong Xu, Frederick A. Fletcher, Thomas C. Boone, Ming-Shi Chang, Ulla M. Sarmiento, Russell C. Cattley	2002	42
4	Osteoprotegerin Ligand Modulates Murine Osteoclast Survival in Vitro and in Vivo American Journal Of Pathology ·David L. Lacey, Hong Tan, John Lu, Steven L. Kaufman, Gwyneth Van, Wanrang Qiu, Alana Rattan, Sheila Scully, Frederick A. Fletcher, Todd Juan, Michael J. Kelley, Teresa L. Burgess, William J. Boyle, Anthony Polverino	2000	321
5	Ectopic overexpression of c-mpl by retroviral-mediated gene transfer suppressed megakaryopoiesis but enhanced erythropoiesis in mice Experimental Hematology ·Xiaoqiang Yan, David L. Lacey, Chris Saris, Sharon Mu, David J. Hill, Robert G. Hawley, Frederick A. Fletcher	1999	16
6	A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans Experimental Hematology ·Graham Molineux, Olaf Kinstler, Bob Briddell, Cynthia Hartley, Patricia McElroy, Patrick J. Kerzic, Weston Sutherland, Greg Stoney, Brent Kern, Frederick A. Fletcher, Art Cohen, Elliot Korach, Tom Ulich, Ian McNiece, Pamela Lockbaum, Mary Ann Miller‐Messana, Sheila Gardner, Thomas R. Hunt, G Schwab	1999	197
7	Marrow repopulating cells in mobilized PBPC can be serially transplanted for up to five generations or be remobilized in PBPC reconstituted mice Bone Marrow Transplantation ·XQ Yan, Y Chen, Cynthia Hartley, Patricia McElroy, Frederick A. Fletcher, IK McNiece	1998	5
8	Identification and Mapping ofCasp7,a Cysteine Protease Resembling CPP32β, Interleukin-1β Converting Enzyme, and CED-3 Genomics ·Todd Juan, Ian McNiece, Julie Argento, Nancy A. Jenkins, Debra J. Gilbert, Neal G. Copeland, Frederick A. Fletcher	1997	31
9	cDNA cloning and chromosomal mapping of mouse fast skeletal muscle troponin T Mammalian Genome ·Anne Koch, Todd Juan, Nancy A. Jenkins, Debra J. Gilbert, Neal G. Copeland, Ian McNiece, Frederick A. Fletcher	1997	4
10	Chronic Expression of Murine flt3 Ligand in Mice Results in Increased Circulating White Blood Cell Levels and Abnormal Cellular Infiltrates Associated With Splenic Fibrosis Blood ·Todd Juan, Ian McNiece, Gwenneth Van, David L. Lacey, Cynthia Hartley, Patricia McElroy, Yu Sun, Julie Argento, David J. Hill, Xiao-Qiang Yan, Frederick A. Fletcher	1997	24
11	Assignment of the gene (EPLG2) encoding a high-affinity binding protein for the receptor tyrosine kinase Elk to a 200-kilobasepair region in human chromosome Xq12 Genomics ·Frederick A. Fletcher, Kay Huebner, Lisa G. Shaffer, Nicholas D. Fairweather, Anthony P. Monaco, Ulrich Müller, Teresa Druck, Denise K. Simoneaux, Jamel Chelly, John W. Belmont, M P Beckmann, Stewart D. Lyman	1995	9
12	Analysis of the intra-epithelial lymphocyte compartment in SCID mice that received co-isogenic CD4+ T cells. Evidence that mature post-thymic CD4+ T cells can be induced to express CD8 alpha in vivo. The Journal of Immunology ·Philip Morrissey, K Charrier, D A Horovitz, Frederick A. Fletcher, J D Watson	1995	58
13	Genomic Organization and Chromosomal Localization of Mouse Eplg2, a Gene Encoding a Binding Protein for the Receptor Tyrosine Kinase Elk Genomics ·Frederick A. Fletcher, Blair R. Renshaw, Tamy Hollingsworth, Peter Baum, Stewart D. Lyman, Nancy A. Jenkins, Debra J. Gilbert, Neal G. Copeland, Barry L. Davison	1994	12
14	Molecular cloning of a ligand for the flt3flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells Cell ·Stewart D. Lyman, L James, Tim Vanden Bos, Peter de Vries, Ken Brasel, Brian Gliniak, L.Tamaralayne Hollingsworth, Kathleen S. Picha, Hilary J. McKenna, Roxanne R. Splett, Frederick A. Fletcher, Eugene Maraskovsky, Terry Farrah, Diane Foxworthe, Douglas E. Williams, M P Beckmann	1993	444
15	Healing of Foot Ulcers in Immunosuppressed Renal Transplant Patients Clinical Orthopaedics and Related Research ·Frederick A. Fletcher, Michael C. Ain, Richard L. Jacobs	1993	16
16	Recent progress in the discovery and invention of novel hematopoietic cytokines Critical Reviews in Oncology/Hematology ·Frederick A. Fletcher, Douglas E. Williams	1992	4
17	Effects of Leukemia Inhibitory Factor (LIF) on Gene Transfer Efficiency into Murine Hematolymphoid Progenitors Advances in experimental medicine and biology ·Frederick A. Fletcher, Kateri Moore, Douglas E. Williams, Dirk Anderson, Charles R. Maliszewski, John W. Belmont	1991	1
18	Leukemia inhibitory factor improves survival of retroviral vector-infected hematopoietic stem cells in vitro, allowing efficient long-term expression of vector-encoded human adenosine deaminase in vivo. The Journal of Experimental Medicine ·Frederick A. Fletcher, Kateri Moore, Malka Ashkenazi, P.C. de Vries, Paul A. Overbeek, Douglas E. Williams, John W. Belmont	1991	46
19	Expression vectors for human adenosine deaminase gene therapy Genome ·Kateri Moore, Frederick A. Fletcher, Raye Lynn Alford, Deborah Kay Villalon, D Hawkins, Grant R. MacGregor, C. Thomas Caskey, John W. Belmont	1989	3
20	A convenient synthesis of unsymmetrical acyclic imides The Journal of Organic Chemistry ·Robert B. Bates, Frederick A. Fletcher, Kim D. Janda, W. A. Miller	1984	13

About Frederick A. Fletcher

Frederick A. Fletcher is a scholar working on Hematology, Immunology, Genetics, Transplantation and Oncology, having authored 34 papers that have together received 2.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), T-cell and B-cell Immunology (4 papers), RNA Interference and Gene Delivery (4 papers), Cytokine Signaling Pathways and Interactions (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Immune Cell Function and Interaction (3 papers), RNA modifications and cancer (3 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Hematology (632 citations), Genetics (309 citations), Immunology (556 citations), Oncology (700 citations) and Orthopedics and Sports Medicine (114 citations). Frederick A. Fletcher has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include David L. Lacey, Todd Juan, David J. Hill, Yu Sun, Douglas E. Williams, Gwyneth Van, Sheila Scully, Stewart D. Lyman, M P Beckmann and Hilary J. McKenna. Their work appears in journals such as Blood, The Journal of Immunology, Genomics, Experimental Hematology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact